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the islets; after a substantial delay, destruction of theAntonio Gonzalez,* Jonathan D. Katz,*‖
insulin±producing b cells ensues, leading to loss of glu-Marie-GenevieÁ ve Mattei,² Hitoshi Kikutani,³
cose homeostasis and progression to diabetes. The eti-Christophe Benoist,*§ and Diane Mathis*
ology and pathogenesis of IDDM are clearly complex,* Institut de GeÂ neÂ tique et de Biologie
perhaps explaining why they remain largely a mystery.MoleÂculaire et Cellulaire
We still do not know why self-tolerance and immunoreg-Centre National de la Recherche
ulatory systems break downÐwhy antigens normallyScientifique/INSERM
ignored by the immune system seem so provocative to1 rue Laurent Fries
the lymphocytes of diabetic individuals.67404 Illkirch
Correspondingly, the genetics of IDDM are very com-Strasbourg
plicated. This disorder is known to have an importantFrance
genetic component, because 38% of an affected twin's²FaculteÂ de MeÂdecine de la Timone
siblings are also diabetic (Verge et al., 1995), but noINSERM U406
culprit genes have been identified definitively. The main27 Boulevard Jean Moulin
exception is the major histocompatibility complex (MHC),13385 Marseille Cedex 5
whose class II genes represent the dominant suscepti-France
bility factor in both the human and murine disorders.³Division of Molecular Immunology
The influence of another 15±20 susceptibility loci hasResearch Institute for Microbial Diseases
been documented. Polymorphism in a minisatellite withinOsaka University
the human insulin gene locus has been identified (Ben-3-1, Yamada-oka, Suita
nett et al., 1995), and the analysis of some of the murineOsaka 565
loci by constructing congenic strains is underway (Yui
Japan
et al., 1996; Denny et al., 1997; Podolin et al., 1997). Yet
most of these loci alone have a very limited impact on
disease, and a comprehensive understanding of the full
Summary genetic influences on diabetes will be extraordinarily
difficult (Wicker et al., 1995; Owerbach and Gabbay,
Autoimmune diabetes in both the human and the non- 1996; Vyse and Todd, 1996).
obese diabetic mouse has elaborate genetics; in the Several groups have developed simplified models of
latter case, the disease is influenced by at least 15±20 IDDM via transgenesis (reviewed in Benoist and Mathis,
loci. Weanticipated that the genetics would be simpler 1993; Mueller and Sarvetnick, 1995), focusing on one
in the BDC2.5 T cell receptor transgenic mouse model particular player or event in the disease process. To
of diabetes, wherein many T cells express a particular highlight factors influencing the production and behav-
diabetogenic specificity. Initiation of insulitis in this ior of autoreactive T cells, we created the BDC2.5 line
model was the same on the two genetic backgrounds of transgenic (Tg) mice, which carries the rearranged T
analyzed, but the kinetics and penetrance of diabetes cell receptor (TCR) genes from a diabetogenic T cell
were strikingly different, permitting us to focus on ge- clone reactive to a b cell±specific antigen (Haskins et al.,
netic influences during a defined window of disease 1989; Katz et al., 1993). There are no signs of tolerance
progression. The differences correlated with varia- induction in these mice but early and extensive leuko-
tions in five genomic intervals, certain ones of which cyte infiltration into the islets; insulitis persists for sev-
eral months before a transition to terminal islet destruc-have been previously implicated in susceptibility to
tion and diabetes. This terminal phase can be provokedautoimmune disease. This reductionist approach indeed
rapidly by the transfer of BDC2.5 T cells activated insimplified the analysis of diabetes susceptibility loci.
vitro under conditions favoring differentiation to the T
helper (Th)-1 phenotype (Katz et al., 1995). It is not clear
Introduction what factors keep the autoimmune attack in check for
such prolonged periods or what eventually disrupts the
Insulin-dependent diabetes mellitus (IDDM), in human equilibrium (AndreÂ et al., 1996). It is important to resolve
patients as well as in the nonobese diabetic (NOD) these issues given that the human and NOD diseases
mouse model, has become a standard for the genetic appear to have a similar biphasic course.
The BDC2.5 Tg line is a potentially powerful tool fordissection of polygenic diseases. This autoimmune dis-
analyzing the genetics of the disease process. It allowsorder is mediated primarily by T lymphocytes reactive
one to bypass events involved in the generation andto antigens expressed by pancreatic islet b cells (Bach,
expansion of the repertoire of autoimmune T cells, which1994; Tisch and McDevitt, 1996). In an initial phase
are preformed in the Tg mice, and to focus on the latertermed insulitis, T cells and other leukocytes infiltrate
steps of diabetes development. Our hope was that this
reductionist approach would reduce significantly the§To whom correspondence should be addressed (e-mail: cb@
number of genetic loci for which to account. Here, weigbmc.u-strasbg.fr).
have exploited the BDC2.5 TCR Tg model to identify and‖ Present address: Department of Pathology, Washington University
map loci that control the penetrance and time course ofSchool of Medicine, 660 South Euclid Avenue, Campus Box 8118,
St. Louis, Missouri 63110. diabetes.
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of the MHC but has all other genes from the B6 strain.
Thus, the final lines carried the BDC2.5 TCR transgenes
together with selecting H2g7 MHC alleles but had differ-
ent alleles at all other loci; hereafter, they will be referred
to as BDC2.5/NOD and BDC2.5/B6g7.
The two lines showed thymic positive selection of T
cells displaying the BDC2.5 TCR specificity as well as
peripheral seeding. (We did note a somewhat more ef-
fective selection on the B6 background, the relevance
of which is discussed at length below.) A plot of the
incidence of spontaneous diabetes in the two Tg lines
is shown in Figure 1B. BDC2.5/B6g7 animals had a very
fast onset of diabetes. Some were already diabetic at
3 weeks of age, and the the most frequent age of onset
was 6 weeks; the incidence of diabetes in several inde-
pendent cohorts already averaged 58.7% at 10 weeks.
The animals that were free of diabetes at 10 weeks of
age essentially remained resistant thereafter (Figure 1C).
In contrast, disease appeared very slowly in BDC2.5/
NOD mice; only 4.9% were diabetic before 12 weeks,
and fewer than 20% were diabetic by 20 weeks of age
(Figure 1B). No sex bias was apparent in either case.
These results are consistent with our initial observa-
tions on early NOD backcrosses of the BDC2.5 TCR Tg
line (Katz et al., 1993), in that disease also appeared
after 15±20 weeks. However, the incidence of disease
has decreased significantly. This could be due to the
more complete backcross onto the NOD background
(see below) or to some degree of selection against
transgene potency in successive crosses.
The present comparison suggests that polymorphic
background genes that differ in B6 and NOD mice con-
trol the installation of stable insulitis versus a rapid tran-
Figure 1. Genetic Background Effect on Diabetes of BDC2.5 TCR sition to diabetes (previously termed checkpoint 2 [Katz
Tg Mice
et al., 1993; AndreÂ et al., 1996]). As discussed at length
(A) Parallel backcrosses of the BDC2.5 transgene onto the NOD and
below, B6 mice, otherwise not prone to autoimmuneB6.H2g7 backgrounds.
disease, carry the susceptibility alleles.(B) Cumulative incidence of diabetes in BDC2.5/NOD (n 5 41) and
BDC2.5/B6g7 mice (n 5 46). All of the mice examined were BDC2.5
Tg and H2g7 homozygotes.
(C) Histogram showing the age of onset of diabetes in the BDC2.5/ Early-Onset Diabetes Reflects a Rapid
B6g7 mice (same cohort as in [B]). Evolution of Insulitis
In the original description of BDC2.5/NOD mice, we re-
ported that insulitis follows an interesting time course:Results
absent before 3 weeks of age then appearing abruptly
(Katz et al., 1993). Thus, two scenarios might have beenC57Bl/6 Genes Promote Accelerated
envisaged to explain the early diabetes in BDC2.5/B6g7Diabetes in BDC2.5 TCR Tg Mice
mice: a precocious insulitis, starting at birth and ragingMany of the T cells in BDC2.5 TCR Tg mice express the
destructively in the young pancreas, or an insulitis withtransgene-encoded receptor, specific for an unknown
the same time of onset but of a more destructive nature.pancreatic islet b cell antigen presented by the MHC
To distinguish between the two, we performed a histo-class II Ag7 molecule (the NOD allele). Ag7 is required
logical analysis of hematoxylin±eosin-stained pancreatafor thymic positive selection of cells expressing the
from BDC2.5/B6g7 and BDC2.5/NOD mice of differentBDC2.5TCR as well as for their peripheral reactivity (Katz
ages. For the NOD background animals, insulitis waset al., 1993). Preliminary data suggested that the genetic
absent at day 12, appeared at day 18, and was morebackground on which the TCR transgenes were carried
extensive at day 24 (Figure 2A). It progressed smoothly,influenced the character of the disease, prompting us
taking an organized appearance with a well-defined bor-to investigate genetic influences more systematically
der between b cells and the large homogeneous masses(Figure 1A). Parallel backcrosses onto the NOD/Lt and
of infiltrating cells (Figures 2Ba and 2Bb).C57Bl/6(B6) backgrounds were performed for 12 gener-
For the B6 background animals, the kinetics wereations, resulting in greater than 99.95% NOD and B6
essentially the same, with insulitis first detected at daygenotypes, respectively. Mice on the B6 background
18 in the majority of mice (Figure 2A). However, thewere then crossed for two generations with the MHC-
congenic line B6.H2g7, which carries the g7 haplotype aspect of the infiltrate was markedly different: the onset
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Figure 2. Effect of the Genetic Background
on the Intensity but Not the Timing of Insulitis
in BDC2.5 TCR Tg Mice
(A) Percentage of pancreatic islets showing
mononuclear infiltrates in BDC2.5 Tg mice on
the NOD and B6.H2g7 backgrounds at 12, 18,
and 24 days of age.
(B) Representative hematoxylin-eosin±stained
sections of pancreata from 18- and 24-day-
old BDC2.5/NOD and BDC2.5/B6g7 mice.
Arrows in (e) point to apoptotic figures. 103
objective, (a), (c), (d), and (f); 403 objective,
(b) and (e).
was much more aggressive, appearing as a severe in- A Few Recessive B6 Genes Confer Susceptibility
to Early-Onset Diabetesflammatory reaction with marked edema around the is-
Given the striking difference in the diabetes phenotypeslets and large numbers of lymphocytes and inflamma-
of BDC2.5/NOD and BDC2.5/B6g7 mice, we performedtory cells in swollen connective spaces, spreading
a genetic analysis to identify the loci controlling diseasetoward the exocrine acini (Figure 2Bd); the attacking
aggressiveness. As a first step, F1 mice were generatedcells penetrated the islets more aggressively, either di-
by mating BDC2.5/NOD females with B6.H2g7 males (Fig-viding them by tracts of infiltration or appearing as a
ure 3A). Sixty Tg mice of the resulting progeny wereªswarm of beesº on the sections (Figures 2Bd and 2Be);
monitored for diabetes development (Figure 3B). Fewapoptotic condensations within the b cells were com-
F1 mice became diabetic, and the delayed onset mir-mon (e.g., Figure 2Be); and the strong inflammatory pro-
rored that of parental BDC2.5/NOD animals (12% inci-cess was also deleterious to exocrine acinar cells in the
dence by 20 weeks, predominantly in females). There-vicinity of the islets (Figure 2Bd). Curiously, this extreme
fore, the B6 alleles at the loci that determine early-onsetpicture was less frequent in day-24 sections (Figure 2Bf),
diabetes are recessive in the F1 generation.as though an initial burst of inflammatory activity was
Subsequently, we backcrossed onto the susceptiblecoming at least partially under control. (Note, however,
B6 background. After mating BDC2.5 Tg F1 mice withthat the BDC2.5/B6g7 day 24 group is somewhat biased,
B6.H2g7 animals, we obtained 665 BC1 offspring, ofgiven that a proportion of the animals had already be-
which 338 were Tg (Figure 3A). The BC1 Tg mice werecome diabetic and were not included in the histological
monitored for diabetes starting from 2 weeks of age. Astudy.) These images of hyperaggressive insulitis seen
significant fraction (23.1%) were diabetic by 10 weekswith BDC2.5/B6g7 mice were never seen on the NOD
of age; the most frequent time of onset was 6 weeks,background. However, they are very reminiscent of what
just as in BDC2.5/B6g7 animals (Figure 3C). Thus, thewe observed after transfer of activated Th1-type BDC2.5
parental early-onset phenotype seemed to reemergecells into neonatal NOD recipients (Katz et al., 1993) or
rapidly upon backcrossing. The high frequency of earlyafter treating BDC2.5/NOD mice with cyclophospha-
diabetes development in the BC1 generation suggestsmide (AndreÂ et al., unpublished data).
that one or only a few recessive B6 alleles are responsi-Thus, it seems that in BDC2.5/NOD mice some ele-
ble for this phenotype.ments are capable of restraining the insulitis for months,
keeping it nonaggressive and inhibiting the transition to
diabetes. In BDC2.5/B6g7 animals, insulitis is far more Identification of the B6 Loci that Promote
explosive and damaging from the outset, as if the pro- Early-Onset Diabetes
cesses that can restrain the aggressiveness of infiltrat- Next, we performed a genome-wide scan, assaying sim-
ple sequence length polymorphisms (SSLPs) to localizeing T cells are absent or at least substantially muted.
Immunity
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BC1 animals (up to a total of 89 mice). Finally, 12 loci
that still showed some degree of linkage after testing
of this second cohort (with very loose criteria; pointwise
P , 0.05) were investigated further by examining 29
additional microsatellites in the vicinity of the initial
markers to ensure that linked loci were not falling be-
tween the first-round markers. In addition, the sampling
of nondiabetic animals was extended. The data from
this scan are reported in Table 1; results and statistical
analyses for the strongest linkages arecompiled inTable
2 and Figure 4.
Four regions showed an association with early-onset
diabetes, exhibiting a preponderance of b/b genotypes
spanning several neighboring markers. The strongest
association (pointwise x2 5 17.1; P 5 3 3 1025) was
found with a stretch on chromosome 7, covering a wide
plateau between markers D7Nds6 and D7Mit232 (22 cM
according to the Massachusetts Institute of Technology
[M.I.T.] database, see below). The statistical P values
at these positions put them well within the range of
significant linkage, according to the stringent criteria
proposed by Lander and Kruglyak (1995). This bias was
reversed in the nondiabetic cohort, where the heterozy-
gous genotypes were more frequent, confirming the sig-
nificance of the linkage (Table 2). The width of this
region, coupled with the 28 recombination events be-
tween D7Nds6 and D7Mit232 among the 89 diabetic
mice (with 14 single homozygotes at either of the loci),
suggests strongly that there are two closely linked loci
on chromosome 7. This possibility was confirmed by
Figure 3. A Few B6 Genes Conferring Susceptibility to Early-Onset logistic regression analysis (Table 2, and see below).
Diabetes These loci will tentatively be referred to as aggressive
(A) Breeding setup: BDC2.5/NOD females were crossed with B6.H2g7 insulin-dependent diabetes (aid) 1 and 2.
males, and the resulting TgF1 progeny were backcrossed with
Another region of association resided on chromo-B6.H2g7 mice to yield BC1 offspring.
some 1, the maximum bias with marker D1Mit22 at 32(B) Cumulative incidence of diabetes in BDC2.5/F1 mice (n 5 60)
cM. Association of this locus was strong (pointwise x2 5and in BDC2.5/BC1 mice (n 5 338). Data for the parental strains
(Figure 1) are included for comparison. 12.24; P 5 5 3 1024), with a level of significance well
(C) Histogram showing the age of onset of diabetes in the BDC2.5/ within thesuggestive linkage and close to the significant
BC1 mice (same cohort as in [B]). linkage range according to the same criteria. Regions
of weak association were found on chromosomes 2 and
15, centered around D2Mit305 at 60 cM and D15Mit235
genetic elements that cosegregate with the early-onset at 33 cM (pointwise x2 5 9.45; P 5 2 3 1023, suggestive
diabetes phenotype in the BC1 cohort. This was accom- of linkage).
plished in three steps. Initially, we used 80 polymorphic No other region of significant association was found.
SSLP markers that distinguish the NOD and B6 alleles; Several markers (e.g., onchromosomes 4 and 6) showed
the markers covered approximately 95% of the 19 au- a preponderance of b/b homozygotes, but only at a level
tosomes with a mean interval of 20 cM and included all of significance that falls in the range of the false positive
of the chromosomal regions associated previously with outcomes expected during such genome-wide searches.
diabetes in NOD mice (Idd loci). We analyzed the segre- A locus on chromosome 3 (in the vicinity of D3Mit57),
gation of this set of markers in 40 BC1 mice that had which also failed to attain the suggestive range of signifi-
succumbed to diabetes before 12 weeks; cosegregation cance, showed a heterozygote bias among diabetic
was reflected by preferential transmission of the B6 al- mice, possibly indicative of a NOD susceptibility locus.
lele in the diabeticmice. Linkage of a given microsatellite The strength of association of these three regions with
to a locus favoring early-onset diabetes should show a early-onset diabetes is insufficient to affirm or exclude
preponderance of the homozygous (b/b) over the het- their involvement; thus, they will not be considered fur-
erozygous (b/n) genotype in diabetic animals; unlinked ther in this report.
loci should show an even distribution. Thirty nondiabetic This genome-widesearch also uncovered the location
Tg BC1 mice were also examined to exclude transmis- of the integration site of the BDC2.5 TCR transgene, which
sion distortions unrelated to the diabetic phenotype. In was in chromosome 13 near the D13Mit125 marker. A
the next phase, 38 microsatellite markers that showed strong bias to the heterozygous genotype was found in
some segregation bias (chosen so that the probability Tg mice, whether diabetic (3:26) or nondiabetic (6:25),
of missing a significant linkage would be ,5%) were reflecting that the transgene originated from the BDC2.5/
NOD line. Since the BDC2.5 TCR Tg line is being usedstudied in an additional cohort of early-onset diabetic
Genetic Control of Diabetes Progression
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Table 1. Results of the Genome SSLP Scan for Loci Associated with Early-Onset Diabetes
Chr cM Marker Ho He x2 Chr cM Marker Ho He x2
1 9.8 D1Mit372 52 29 6.53 8 14.2 D8Mit291 26 26
19.7 D1Mit321 57 32 7.02 38.3 D8Mit249 26 26
32.6 D1Mit22 61 28 12.24 57.9 D8Mit316 25 27
41.5 D1Mit24 60 29 10.80 71.0 D8Mit324 25 27
52.5 D1Mit48 60 29 10.80
60.1 D1Mit386 56 33 5.94 9 12.0 D9Mit297 25 27
69.9 D1Mit286 52 37 23.0 D9Nds6 21 19
82.0 D1Mit33 28 24 41.5 D9Mit133 37 52
104.9 D1Mit221 23 27 60.1 D9Mit212 22 30
2 5.5 D2Mit2 25 24 10 9.8 D10Mit16 29 22
28.4 D2Mit297 29 23 33.9 D10Mit115 25 27
50.3 D2Mit44 51 34 50.3 D10Mit95 24 28
55.7 D2Mit395 56 32 6.55 69.9 D10Mit14 25 27
60.1 D2Mit305 59 30 9.45
64.5 D2Mit209 57 32 7.02 11 9.8 D11Mit152 27 25
68.9 D2Mit47 54 35 4.06 31.7 D11Mit260 29 23
91.8 D2Mit346 40 49 40.4 D11Nds1 26 22
48.1 D11Mit212 21 19
3 9.8 D3Mit203 29 23 74.3 D11Mit61 18 22
14.2 D3Mit21 29 23
30.6 D3Mit49 40 49 12 9.8 D12Mit136 27 25
33.9 D3Nds11 37 52 28.4 D12Mit156 23 26
38.3 D3Mit103 35 54 4.06 51.4 D12Mit141 52 36
40.4 D3Mit57 36 52
45.9 D3Mit291 35 54 4.06 13 13.1 D13Mit61 3 26
60.6 D3Mit147 37 48 26.2 D13Mit125 3 17
47.0 D13Mit262 6 14
4 10.9 D4Mit171 48 41
18.6 D4Mit23 53 36 14 2.2 D14Nds1 43 45
30.6 D4Mit178 54 35 4.06 3.3 D14Mitll 44 45
39.3 D4Mit145 51 38 31.7 D14Mit234 40 49
54.6 D4Mit12 45 44 47.0 D14Mit193 40 47
61.2 D4Mit71 43 46 63.5 D14Mit75 33 39
71.0 D4Mit160 36 53
74.0 D4Nds16 37 52 15 10.9 D15Mit180 50 37
82.0 D4Mit59 35 53 16.4 D15Mit255 52 37
17.5 D15Mit206 52 36
5 0.0 D5Mit346 22 20 24.0 D15Mit121 54 32 5.63
5.5 D5Mit61 23 18 32.8 D15Mit235 59 30 9.45
28.4 D5Mit113 48 41 35.0 D15Mit71 57 32 7.02
51.4 D5Mit210 39 45 49.2 D15Mit159 57 32 7.02
77.6 D5Mit223 31 37 55.7 D15Mit147 55 34 4.96
57.9 D15Mit193 51 35
6 9.8 D6Mit223 24 28
29.5 D6Mit261 26 26 16 6.6 D16Mit131 27 25
51.4 D6Mit111 52 37 26.2 D16Mit195 32 31
55.7 D6Mit291 54 35 4.06 33.9 D16Mit140 51 37
63.4 D6Mit14 54 35 4.06 40.4 D16Mit178 52 37
66.7 D6Mit374 48 41 50.3 D16Mit128 50 37
7 0.0 D7Mit152 61 28 12.24 17 0.0 D17Mit19 36 39
4.4 D7Nds6 64 25 17.09 7.7 D17Mit28 NA NA
5.5 D7Mit245 64 25 17.09 12.0 D17Mit176 NA NA
12.0 D7Mit308 64 25 17.09 29.5 D17Mit87 40 43
16.4 D7Mit228 63 26 15.38 42.5 D17Mit207 26 25
18.6 D7Nds5 62 27 13.76
26.2 D7Mit232 64 25 17.09 18 9.8 D18Mit120 27 23
29.1 D7Mit30 60 29 10.80 31.7 D18Mit188 25 27
33.9 D7Mit123 55 29 7.88
41.5 D7Mit253 52 36 19 8.7 D19Mit79 26 26
49.2 D7Mit105 49 36 32.8 D19Mit27 22 30
64.5 D7Mit242 38 46 55.7 D19Mit71 25 27
The Ho and He columns indicate, for each of the 109 markers used, the number of diabetic BDC2.5/BC1 mice that were homozygous or
heterozygous, respectively, for the B6 alleles. x2 values of the goodness-of-fit test are shown only when the distribution of genotypes differs
from the expected 50:50 with P , 0.05. Shaded areas highlight the four regions segregating with the early-onset diabetes. The boxed region
on chromosome 13 corresponds to the insertion site of the BDC2.5 transgenes indicated by a marked increase in the NOD alleles. Map
positions (in centimorgans) were taken from the Whitehead Institute/M.I.T.-Center for Genome Research.
NA, nonapplicable because both the NOD and B6.H2g7 parental mice carried the NOD alleles for these markers.
Chr, chromosome.
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Table 2. Statistical Data for the Loci Associated with Early-Onset Diabetes
Diabetics Nondiabetics Combined Data
Multivariate
Analysisa
Locus Marker Ho He x2 b Pc m(T)d Ho He x2 e Pc m(T)d Pf
Significant linkage
aid1 D7Nds6 64 25 17.09 0.00003 0.017 33 54 20.53 6 3 1026 0.004 0.03
aid2 D7Mit232 64 25 17.09 0.00003 0.017 29 58 26.07 3 3 1027 0.00025 0.0001
Suggestive linkage
D1Mit22 61 28 12.24 0.0005 0.20 40 47 9.16 0.0025 0.77 0.002
D2Mit305 59 30 9.45 0.0021 0.67 33 54 14.18 0.0002 0.09 0.0016
D15Mit235 59 30 9.45 0.0021 0.67 35 52 12.01 0.0005 0.20 0.005
Nonsignificant
D3Mit103 35 54 4.06 0.044 6 39 48 NS
D3Mit291 35 54 4.06 0.044 6
D4Mit178 54 35 4.06 0.044 6 49 38 NS
D6Mit291 54 35 4.06 0.044 6
D6Mit14 54 35 4.06 0.044 6 45 42 NS
a Logistic regression analysis of the combined data for the five markers showing significant bias.
b Goodness-of-fit test against the expected 50:50 distribution.
c Probability corresponding to the x2 value.
d Number of unlinked markers, which will show, by chance, a similar bias in a whole genome scan (Lander and Kruglyak, 1995).
e 2 3 2 contingency table comparing the genotypes in diabetic and nondiabetic BC1 mice.
f Probability corresponding to the t value for the parameters of the logistic regression model.
Ho, homozygous.
He, heterozygous.
NS, not significant.
by us and others in a variety of diabetes studies, it The Identified Loci Account for Most
of the Early-Onset Diabetes in Miceseemed worthwhile to confirm this localization by in
situ hybridization on metaphase chromosome spreads. of the B6 Background
Once the putative susceptibility regions were identified,Splenocytes from a BDC2.5TCR Tg mouse were hybrid-
ized with a probe from the TCR-a constant segment. it was important to determine their relative importance,
their contribution to the phenotype of early-onset diabe-Consistent with the microsatellite analysis, hybridization
signals were detected on chromosome 13C (as well as tes in BDC2.5/B6g7 mice, and their interactions. Initially,
we evaluated the genotypic risk ratio (GRR) (Risch etat the normal TCR-a locus on chromosome 14D) (data
not shown). al., 1993) at the different loci. Pointwise GRRs were 0.69
Figure 4. Schematic Representation of the Susceptibility Loci for Early-Onset Diabetes
Map of mouse chromosomes 7, 1, 2, and 15 showing the loci associated with the early-onset diabetes in the BDC2.5/BC1 mice. Length of
the horizontal bars represents the association of the different SSLP markers with early-onset diabetes (x2 values in the goodness-of-fit test).
Filled bars, linked markers; striped bars, unlinked markers. The relative positions (in centimorgans) of the SSLP markers are from the M.I.T.
database, even in instances when the genetic distances in our crosses differed significantly. Potentially relevant genes are represented to
the left of the chromosomes; for consistency, their relative map positions from the Mouse Genome Database (http://www.informatics.jax.org/
mgd.html) are shown anchored on the scale of the M.I.T. genetic map. Further on the left, previously reported autoimmune susceptibility loci
are indicated. The size of these regions is based on the published data: Idd7 (Ghosh et al., 1993; McAleer et al., 1995), Sle3 (Morel et al.,
1994), Lbw5 (Kono et al., 1994), Orch5 (Meeker et al., 1995), Idd5 (Cornall et al., 1991; Garchon et al., 1991; Ghosh et al., 1993), and Idd13
(Serreze et al., 1994). When the available data were imprecise, we display 15 cM to either side of the position of the reported marker. Syntenic
correspondences with human IDDM loci are approximate (IDDM3 [Field et al., 1994], IDDM7 [Copeman et al., 1995; Owerbach and Gabbay,
1995; Nistico et al., 1996], and IDDM13 [Morahan et al., 1996]); the size of these loci has been set arbitrarily at 10 cM.
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4.0% 6 0.5% of CD41CD82 thymocytes stain with anti-
Va2 on the B6.H2g7 or NOD backgrounds, respectively
(we cannot measure the expression of the BDC2.5 Tg
Va chain directly, owing to a lack of a suitable reagent).
Similar results were obtained with other reagents de-
tecting other Va chains of endogenous origin (data not
shown). Since 10%±12% of T cells normally express
Va2 in NOD or B6.H2g7 mice, we can estimate that 60%
of the CD41 mature thymocytes bear the BDC2.5 TCR
on the NOD background, and about 90% bear it on the
B6.H2g7 background.
This observation indicates that the genetic back-
ground influences the selection of BDC2.5 T cells. This
does not correspond to a generally more efficient selec-
tion on the B6.H2g7 background, because non-Tg NOD
Figure 5. Equivalent Numbers of T Cells Bearing Endogenous TCRs and B6.H2g7 mice have roughly the same proportions of
in Diabetic and Healthy BC1 Mice mature CD41 cells; however, it may correspond to the
Percentages of CD41 T cells bearing a Va2 chain in the blood of differential influence of peptides from each background
BDC2.5 Tg BC1 mice. Blood samples were taken prospectively at
in stimulating or antagonizing selection. More germane28 days of age, and the mice were monitored for diabetes to 12
to the present study is whether this differential selectionweeks. Mean values were 5.4% 6 2.4% in the 15 diabetic mice and
is the cause of the different susceptibility to early-onset5.7% 6 2.4% in the 29 nondiabetic BC1 mice.
diabetes. Such an influence of the frequency of Tg Va
chain expression on the autoimmune phenotype has
for both D7Nds6 and D7Mit232, 0.73 for D1Mit22, and been reported previously (Lafaille et al., 1994; Forster
0.75 for both D2Mit305 and D15Mit235, indicating fairly et al., 1995), in particular for BDC2.5 Tg mice, which
similar overall contributions. GRRs of this magnitude have faster and more frequent diabetes when carrying
place these loci among the most influential NOD Idd loci the severe combined immunodeficient or TCRa null mu-
(Risch et al., 1993). tations (Kurrer et al., 1997) (AndreÂ et al., unpublished
That thebulk of thesusceptibility to early-onset diabe- data).
tes in BDC2.5/B6g7 Tg mice can be accounted for by Could, then, the aid loci act by influencing the effi-
these five loci was indicated by the overall penetrance ciency of BDC2.5 selection? To address this possibility,
(78%) of early-onset diabetes when all are b/b homozy- a cohort of BC1 mice, generated as for the genetic study
gous. This frequency is as high as or higher than that in described above, were analyzed prospectively for en-
parental BDC2.5/B6g7 mice. That each locus contributes dogenous Va2 usage in blood CD41 lymphocytes at 28
independently was also shown by logistic regression days of age and then followed for early-onset diabetes.
analysis (Table 2), which confirmed the independent ef- As shown in Figure 5, we found no difference in Va2
fects of the two loci on chromosome 7. Homozygosity frequency between the mice that developed diabetes
at any one of the loci was not an absolute condition for and those that remained healthy. We also failed to find
early diabetes, but B6 homozygosity on at least one of any correlation between disease occurrence and the
the three strongest loci, aid1, aid2, and D1Mit22, was frequency of endogenous Va rearrangement in thymo-
required. cytes (data not shown). We also found no correlation
Analysis of combined haplotypes was performed to between Va2 levels on thymocytes and SSLP genotypes
evaluate the interactions between these loci. The five at the five loci described above (data not shown). Thus,
loci interact in a cumulative way, diabetes incidence the influence of B6.H2g7 background genes on provoking
increasing with the number of B6-derived susceptibility early-onset diabetes does not stem from an effect on
alleles. Direct examination of the haplotypes of diabetic the selection of the BDC2.5 TCR but rather on how the
mice, as well as log-linear analysis, failed to demon- diabetogenic potential is expressed.
strate any significant epistatic interactions between
these genes. However, the number of animals involved
is too small, given the number of loci, and the applicable Discussion
mathematical models are too general to allow a firm
conclusion at this stage. In BDC2.5 TCR Tg mice on the NOD and B6.H2g7 genetic
backgrounds, the early events of disease pathogenesis
are fixed and equivalent: an anti-islet T cell repertoireDifferential BDC2.5 TCR Selection Does Not
Correlate with the Diabetes Phenotype is preformed, positive selection generates large num-
bers of islet-reactive T cells (Katz et al., 1993); the incit-As mentioned above, we found that the thymic selection
of BDC2.5 T cells was more efficient on the B6 than on ing islet cell antigen is similarly expressed (Haskins et
al., 1989); and the kinetics of T cell invasion of the isletsthe NOD background. This was manifest as a higher
proportion of CD41CD82 mature thymocytes (19.6% 6 are comparable (Figure 2). However, progression to
overt diabetes is markedly different on the two back-1.0% in BDC2.5/B6g7 vs. 10.3% 6 2.8%) and as a lower
proportion of mature thymocytes expressing endoge- grounds: BDC2.5/B6g7 mice develop an IDDM typical in
most features, but, in contrast to the disease in BDC2.5/nous rearranged TCR Va chain genes: 1.1% 6 0.1% or
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NOD or regular NOD animals, there is a quick transition (Figure 4), but it is important to keep in mind that our
mapping data are still too coarse to argue strongly infrom initial islet infiltration to massive destruction of the
insulin±producing b cells. Thus, a genetic analysis of their favor. In the aid1 interval on chromosome 7, an
appealing candidate is Tgfb1 (coding for transformingBDC2.5 Tg mice on the NOD versus B6.H2g7 background
allowed us to focus specifically on a crucial window of growth factor-b1), because this cytokine is known to
have anti-inflammatory activity and has been implicateddisease: unfolding of the destructive potential of the
insulitic lesion. No doubt a reflection of this narrowed in the dampening of autoimmune diseases, including
IDDM (Pankewycz et al., 1992; Wahl, 1994; Hancock etfocus, the genetic influences we observed were simpli-
fied compared with those impinging on NOD mice, as al., 1995). Another gene with a potential role is Zfp36
(encoding zinc finger±binding protein 36), given that aevidenced by the high incidence of aggressive disease
in BC1 mice and that the five loci uncovered in the SSLP null mutation resulted in systemic autoimmunity, appar-
ently through uncontrolled production of tumor necrosisscreen could account for essentially all of the B6/NOD
differential. factor a (Taylor et al., 1996). It hasbeen reported recently
that members of the killer inhibitory receptor family ex-At first it may appear paradoxical that the genome of
the NOD mouse, arguably the best murine model of pressed on natural killer cells and on activated T cells
and macrophages is encoded in a gene complex locatedautoimmune disease, would provide a diabetes-resis-
tant background, while the B6 genome conferred sus- in the proximal region of chromosome 7 (2±4 cM) (Wagt-
mann et al., 1997). These would make attractive candi-ceptibility. However, a balance of susceptibility and re-
sistance alleles within a population is a characteristic dates in an immunoregulatory context. Other genes cod-
ing for molecules involved in the immune system (e.g.,of polygenicdiseases, and nosingle inbred mouse strain
would be expected to carry the full diabetes-predispos- those encoding CD22, CD37, and Bax), whose influence
seems less easily explainable, also map in this regioning complement of the Mus species. Indeed, diabetes-
resistance loci in the NOD genome have been described of chromosome 7.
On chromosome 1, enticing candidates are the genespreviously (Ghosh et al., 1993; McAleer et al., 1995).
Furthermore, the very nature of the NOD strain and the for CD28 and CTLA-4, whose activities regulate recipro-
cally the activation of T cells. Signaling through CD28history of its isolation from an outbred Institute for Can-
cer Research stock (Tochino, 1986) almost guarantee enhances T cell stimulation, whereas CTLA-4±mediated
signals can have a negative effect (Allison and Krummel,that the aid elements would have been eliminated from
the NOD genome; the selection of NOD as a defined 1995). The Nramp1 gene, whose allelic variants deter-
mine susceptibility or resistance to intracellular infec-strain by brother/sister matings imposed a strong selec-
tion pressure for diabetes susceptability but also for the tions, also maps in the vicinity. Nramp1 has pleiotropic
effects on macrophages, regulating priming and activa-ability to reproduce. Thereby, it was preordained that
the resulting mouse would remain healthy during the tion for antimicrobial and tumoricidal activities. The im-
plicated region on chromosome 2 contains the genesprimary ages of reproduction (6±15 weeks) but show
frequent diabetes thereafter. Any aid alleles conferring encoding the inflammatory cytokine interleukin-1. On
chromosome 15, the Ly6C gene maps to the implicatedearly-onset disease would have been incompatible with
survival of the NOD line as it was propagated. aid alleles region, and there are known polymorphisms between
alleles in NOD and nonautoimmune strains (Philbrick etbecome evident in this study because the Tg line was
propagated on the B6 background under the protection al., 1990).
Other alleles predisposing to autoimmune pathologyof the H2b MHC haplotype, which does not allow presen-
tation of the relevant islet cell antigen to BDC2.5 T cells; have been reported to reside in the same genomic inter-
vals as the aid loci (Figure 4). The most intriguing regiononly in the outcross to B6.H2g7 can the disease-acceler-
ating alleles come into play. Therefore, it seems that is certainly that containing aid1±2 on chromosome 7.
Suggestively, it coincides with the NOD Idd7 locus,NOD mice are susceptible to the formation, activation,
and expansion of an autoimmune repertoire, but, at the which is one of the three diabetes resistance loci of the
NOD genome mapped in backcross analyses of diabe-same time, they are quite able to keep the autoimmune
process in check. tes (Ghosh et al., 1993; McAleer et al., 1995). In addition,
aid2 maps in the region syntenic to that which containsIt will be of great importance to decipher the cellular
and biochemical events that are controlled by the aid the IDDM3 locus, linked to diabetes in HLA-susceptible
sib-pairs (Field et al., 1994). The aid1±2 region also en-loci. We have shown previously that diabetes in the
BDC2.5 Tg model is influenced strongly by the Th1/Th2 compasses a similarly spaced pair of loci (Sle3 and
Lbw5) shown to influence the severity of glomerulone-phenotype of the invading T cells (Katz et al., 1995).
However, an influence on theTh1/Th2 balance is unlikely phritis in the NZB/W model of systemic lupus erythema-
tosus (Morel et al., 1994; Kono et al., 1994). Such cluster-to be the sole explanation for the effect of the aid sus-
ceptibility alleles; we have not found a shift toward the ing suggests that different inbred strains may express
allelic variants of proteins that have a role inpathologicalTh1 phenotype in splenocytes from B6 compared with
NOD mice, judged from cytokine production after anti- mechanisms common to several autoimmune models.
The chromosome 1 region is another that overlapsCD3 stimulation in vitro (AndreÂ et al., unpublished data).
Furthermore, if anything, the NOD mouse has been re- with loci implicated previously in diabetes. Idd5 is
probably not relevant because it is a susceptibility locusported tohave defectiveTh2 cytokine production (Rapo-
port et al., 1993; Gombert et al., 1996). for NOD diabetes involved mainly with insulitis (Cornall
et al., 1991; Garchon et al., 1991; Ghosh et al., 1993).What candidate genes are found in the vicinity of the
aid loci? A number of genes appear to be possibilities On the other hand, two human diabetes susceptibility
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and B20.1, specific for Va2 (Gregoire et al., 1991), revealed withloci have been localized to the syntenic region: IDDM7,
Texas±red-labeled anti-rat IgG (Jackson).in the area containing the Cd28/Ctla4 gene pair (Cope-
man et al., 1995; Owerbach and Gabbay, 1995; Nistico
Genetic Mapping and Statistical Analysis
et al., 1996), and IDDM13, slightly more distal, in the Tail DNA was used for polymerase chain reaction amplification with
vicinity of Igfbp2 (Morahan et al., 1996). The chromo- primers specific for microsatellite markers spanning the 19 au-
some 2 region, which shows suggestive linkage, may tosomes. The 80 microsatellite markers used for the screening were
selected from the Whitehead Institute/M.I.T.-Center for Genome Re-overlap with the Idd13 locus identified in a NOD 3 NOR
search database (http://www.genome.wi.mit.edu), spaced at aboutintercross, although NOD mice carried the susceptible
20 cM intervals and discriminating between NOD and B6 alleles (aallele in this instance (Serreze et al., 1994).
few errors were noticed in the M.I.T. database; the full listing of
This reductionist approach to the genetics of diabetes SSLP data for the markers used in this study can be consulted at
seems to have been fruitful. We have defined a relatively http://www-igbmc.u-strasbg.fr/cbdm). Some markers were se-
small number of loci that control a crucial window of lected because they have been associated with diabetes suscepti-
bility in NOD mice (Cornall et al., 1991; Garchon et al., 1991; Todddiabetes pathogenesisÐthe progression from insulitis
et al., 1991; Ghosh et al., 1993; Prins et al., 1993; Morahan et al.,to aggressive b cell destruction. The relevance of these
1994; Ikegami et al., 1995; McAleer et al., 1995). Primers were ob-loci to IDDM in general is underscored by the fact that
tained from Research Genetics (Huntsville, AL) or were synthesized
certain of them appear to correspond to genetic ele- in house. Polymerase chain reaction amplification was done with
ments localized in previous studies of IDDM in standard radiolabeled forward primers as described (Dietrich et al., 1992)
NOD mice or human patients. The speed of the diabetes and the radioactive products run on 6% polyacrylamide sequencing
gels. Data were analyzed with the help of the MapManager softwarereadout and the focus on the defined stage of diabeto-
(a gift from K. F. Manly).genesis that the transgene allows should facilitate
Evaluation of the association between genotype and diabetesgreatly the identification and understanding of thegenes
phenotype was done initially with the x2 test for goodness of fit
involved. against the expected 50:50 distribution. In addition, 87 nondiabetic
mice were studied in the regions that showed a significant bias,
Experimental Procedures and the x2 values of the corresponding 2 3 2 contingency table were
obtained. Significance levels were evaluated according to stringent
Mice guidelines for the interpretation of whole genome studies (Lander
BDC2.5 TCR Tg mice have been described (Katz et al., 1993). The and Kruglyak, 1995). The chance of finding a marker at random
founder was bred onto the NOD or B6 genetic background. The that exceeds the significance level attained by each of the putative
BDC2.5/NOD mice used in these experiments have been back- susceptibility loci in a whole genome screen [m(T)] was estimated
crossed for 12±14 generations onto the NOD background. After 11 as described by Lander and Kruglyak (1995). GRRs were calculated
generations of backcross onto the B6 background, BDC2.5 TCR Tg as described (Risch et al., 1993); the maximum possible GRR for a
mice were crossed with B6.H2g7 congenic mice (backcrossed more recessive susceptibility locus is 0.5 and the minimum is 1.0.
than 26 generations onto the B6 background). The BDC2.5/B6.H2g7 An assessment of the contribution of the individual susceptibility
line is maintained by breeding MHC heterozygotes (b/g7) to avoid loci to the early diabetes phenotype was made by stepwise logistic
genetic drift as a consequence of selective pressure due to early- regression analysis (entry P values were set at 0.05, and exit P was
onset diabetes (H2g7/b mice show a lower incidence of diabetes set at 0.049). Analysis of the interaction of the susceptibility loci
[Luhder et al., submitted]). All animals in the present analyses were was done by analysis of the haplotypes and of their estimated pene-
H2g7/g7 homozygotes. For the genetic analysis, F1 mice were pro- trances. Penetrances were estimated assuming an unbiased Men-
duced by mating BDC2.5/NOD females with B6.H2g7 males; delian distribution of the haplotypes in Tg BC1 mice and adjusting
transgenic BDC2.5 F1 mice were mated with B6.H2g7 mice to pro- for the recombination fraction between the two loci of chromosome
duce the BC1 generation. 7. Also, a log-linear model was fitted to the haplotypes of the diabetic
Mice were typed for the BDC2.5 transgenes either by Southern and nondiabetic BC1 mice to detect interactions between suscepti-
blot analysis of tail DNA with a Va-specific probe (Katz et al., 1993) bility loci and the early-onset diabetes. Statistical analysis was per-
or by fluorescence-activated cell sorter analysis of blood after stain- formed with the STATISTICA software (StatSoft).
ing for Vb4 and CD4.
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